E-mail  |   Log in
News Center
Ningbo Aucheer Biotechnology Co., Ltd
audir
audir
Maternal and Child Health|Strictly observe the screening barriers during pregnancy, precise detection and build a safe defense line for pregnancy

Maternal and Child Health|Strictly observe the screening barriers during pregnancy, precise detection and build a safe defense line for pregnancy

(Summary description)

Maternal and Child Health|Strictly observe the screening barriers during pregnancy, precise detection and build a safe defense line for pregnancy

(Summary description)

 

From the period of pregnancy to the "careful" during pregnancy, health during pregnancy is the top priority of every female individual and family. In the nearly 40 weeks from the confirmation of pregnancy to the completion of childbirth, each pregnant woman needs to undergo an average of nearly 12 pregnancy checkups. The frequency and content of the checkups are constantly adjusted over time, as the gestational age increases. , The function of the obstetric examination has also been transformed into: prevention of neonatal birth defects and maternal idiopathic diseases during pregnancy.

一、Preeclampsa

Preeclampsia is a common serious complication in pregnant women. It refers to abnormal symptoms such as hypertension and proteinuria after 20 weeks of pregnancy, or accompanied by impaired maternal organ function and fetal complications. The incidence of preeclampsia in my country is 2%~5%, causing about 15% of fetuses to be born prematurely and 42% of maternal deaths, seriously affecting the health of mothers and babies. Therefore, screening for early diagnostic markers of preeclampsia, early intervention and monitoring of high-risk preeclampsia pregnant women, prevention and treatment of preeclampsia, and improvement of pregnancy outcomes are of great significance.

二、Prevention of preeclampsia

Nowadays, with the advancement of medical technology and continuous in-depth exploration and research on pre-eclampsia, doctors can identify and discover pre-eclampsia earlier. Studies have shown that placental growth factor (PLGF) is the most capable of identifying pre-eclampsia. Biochemical markers can effectively predict preeclampsia in the early pregnancy and can identify high-risk groups of preeclampsia, so that necessary measures can be initiated as soon as possible to improve placenta formation and prevent or reduce the incidence of preeclampsia. In addition, identifying "at risk" groups can help tailor prenatal monitoring to predict and identify the onset of clinical syndromes and deal with them in a timely manner.

三、Pre-eclampsia screening

In the 2019 FIGO guidelines, it is recommended that all pregnant women should be screened for early preeclampsia through the combination of early pregnancy testing and maternal risk factors and biomarkers in the first trimester. The best combination of testing includes maternal risk factors, mean arterial pressure (MAP) ), serum placental growth factor (PlGF) and uterine arterial pulsatility index (UTPI). The selected high-risk population needs to take early intervention measures. In addition, the latest guidelines for the diagnosis and treatment of hypertension in pregnancy (2020) also mention the latest The study put forward the best prediction method is PLGF combined with maternal factors, MAP, uterine artery pulsatility index (UTPI), higher accuracy.

Anyuxi™ Placental Growth Factor Detection Kit

 

Among all the forces that focus on pre-eclampsia diseases and patients, Aucheer is also one of them. It has been committed to providing professional maternal and child health clinical diagnosis solutions. Anyuxi™ Placental Growth Factor Detection Kit can be used for pre-eclampsia Carry out risk assessment and assist clinical diagnosis to identify preeclampsia. Screen at the right time, identify the enemy's situation, and prevent it early! Regular prenatal screening is conducive to the early detection of prenatal complications. According to the correct guidance of the condition and formulating scientific diagnosis and treatment plans, the significance of prenatal preventive screening can be realized and the purpose of ensuring the health of mothers and babies is achieved.

Anyuxi™ Placental Growth Factor Detection Kit

 

 

Among all the forces that focus on pre-eclampsia diseases and patients, Aucheer is also one of them. It has been committed to providing professional maternal and child health clinical diagnosis solutions. Anyuxi™ Placental Growth Factor Detection Kit can be used for pre-eclampsia Carry out risk assessment and assist clinical diagnosis to identify preeclampsia. Screen at the right time, identify the enemy's situation, and prevent it early! Regular prenatal screening is conducive to the early detection of prenatal complications. According to the correct guidance of the condition and formulating scientific diagnosis and treatment plans, the significance of prenatal preventive screening can be realized and the purpose of ensuring the health of mothers and babies is achieved.

 

图片

 

相关资讯

Aucheer
Contact:86-574-87732259
Technical Support:400-008-6588
Aucheer
Business Mailbox:info1@aucheer.net
HR Mailbox :hr@aucheer.net
Aucheer
Address: North Building B, No. 885, Chunhua Rd., Wangchun Industrial Zone, Haishu District, Ningbo, Zhejiang Province, China 
Aucheer
Aucheer Bio
Aucheer
Aucheer Medical

© 2021 Ningbo Aucheer Biotechnology Co., Ltd | 浙ICP备17032133号-2Powered by www.300.cn